BioWisdom Extends Intelligent Networks Collaboration With AstraZeneca

Jul 19, 2006

NEW YORK (GenomeWeb News) - BioWisdom extended its relationship with AstraZeneca to build Intelligent Networks, BioWisdom said today.

The two companies have been working together for two years. AstraZeneca will also evaluate BioWisdom's Sofia platform.

Financial details were not disclosed.

Breaking News

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.